NONA
EW icon

Ninety One North America’s Edwards Lifesciences EW Stock Holding History

Ninety One North America’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.8M Sell
616,498
-20,832
-3% -$1.75M 2.61% 8
2026
Q1 		$51M Buy
637,330
+69,386
+12% +$5.72M 2.29% 18
2025
Q4 		$48.4M Buy
567,944
+16,545
+3% +$1.36M 1.96% 18
2025
Q3 		$42.9M Buy
551,399
+71,017
+15% +$5.55M 1.94% 20
2025
Q2 		$37.6M Buy
480,382
+152,668
+47% +$11.4M 1.84% 20
2025
Q1 		$23.8M Sell
327,714
-26,289
-7% -$1.88M 1.6% 25
2024
Q4 		$26.2M Sell
354,003
-15,015
-4% -$1.05M 1.62% 25
2024
Q3 		$24.4M Buy
+369,018
New +$26.8M 1.65% 26

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Ninety One North America's EW Position: Q2 2026 in Review

Ninety One North America reduced its Edwards Lifesciences (EW) stake by 3.3% in Q2 2026, selling an estimated $1.75M and leaving 616,498 shares worth $55.8M. The position accounts for 2.61% of the portfolio, ranked #8.

Ninety One North America first reported a position in EW in Q3 2024 and has held it in 8 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Ninety One North America held 616,498 shares of Edwards Lifesciences worth $55.8M as of Q2 2026.
  • Ninety One North America sold 20,832 Edwards Lifesciences shares in Q2 2026, an estimated $1.75M.
  • Edwards Lifesciences made up 2.61% of Ninety One North America's portfolio in Q2 2026, its #8 holding.
  • Ninety One North America first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 8 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Ninety One North America's 13F filing for Q2 2026, filed 16 Jul 2026.